Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02768103 · ClinicalTrials.gov registry record · NA

Neural Adaptation After Tendon Transfer and Training in Tetraplegia

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT02768103: Completed NA study, sponsored by VA Office of Research and Development.

NCT02768103 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02768103, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The number of people in the United States who have survived SCI is estimated to be approximately 273,000 persons. Around 50% of the injuries are to the cervical spine resulting in tetraplegia. An important rehabilitation goal in this population is recovery of upper limb function, which could decrease medical costs and improve their quality of life. Re-establishing active grasp and pinch strength to the hand can be accomplished by surgeries that transfer the tendon of a strong muscle to restore strength to a paralyzed muscle, but the outcomes of the surgeries are variable. The investigators have demonstrated in an ongoing study, the functional gains after surgery can be improved with a focused therapy program to retrain the transferred muscle. The propose of this study is to examine the cortical mechanisms that drive successful muscle re-education after surgery. Understanding the neural (brain) activity associated with functional performance can help to predict who will respond to therapy and will guide evidence-based rehabilitation programs to improve upper limb function in tetraplegia.

Interventions

  • BEHAVIORAL task-based training

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2016-05
Est. Completion 2018-06-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02768103

The ClinicalTrials.gov registry entry for NCT02768103 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which task-based training is the first listed.

NCT02768103 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02768103 about?

NCT02768103 is a clinical study titled "Neural Adaptation After Tendon Transfer and Training in Tetraplegia". The number of people in the United States who have survived SCI is estimated to be approximately 273,000 persons. Around 50% of the injuries are to the cervical spine resulting in tetraplegia. An important rehabilitation goal in this population is recovery of upper limb function, which could decreas...

What is the current status of trial NCT02768103?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2016-05. Estimated completion is 2018-06-30.

What interventions are being tested in trial NCT02768103?

The interventions under investigation include: task-based training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02768103?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.